---
figid: PMC7558805__nihms-1630701-f0006
figtitle: 'Sphingolipid biosynthetic pathways:'
organisms:
- NA
organisms_ner:
- Saccharomyces cerevisiae S288C
- Homo sapiens
pmcid: PMC7558805
filename: nihms-1630701-f0006.jpg
figlink: /pmc/articles/PMC7558805/figure/F6/
number: F6
caption: A. An abbreviated yeast sphingolipid biosynthetic pathway. Phytosphingosine
  (PHS) is highlighted. Treatment of cells with myriocin reduces PHS levels, while
  orm1Δ orm2Δ cells or Aureobasidin A (AbA) treatment of cells increases the PHS levels.
  B. A comparison of the human and yeast sphingolipid biosynthetic pathways.
papertitle: A Cell Cycle Checkpoint for the Endoplasmic Reticulum.
reftext: Maho Niwa. Biochim Biophys Acta Mol Cell Res. ;1867(12):118825-118825.
year: '2021'
doi: 10.1016/j.bbamcr.2020.118825
journal_title: Biochimica et biophysica acta. Molecular cell research
journal_nlm_ta: Biochim Biophys Acta Mol Cell Res
publisher_name: ''
keywords: ''
automl_pathway: 0.8354049
figid_alias: PMC7558805__F6
figtype: Figure
redirect_from: /figures/PMC7558805__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7558805__nihms-1630701-f0006.html
  '@type': Dataset
  description: A. An abbreviated yeast sphingolipid biosynthetic pathway. Phytosphingosine
    (PHS) is highlighted. Treatment of cells with myriocin reduces PHS levels, while
    orm1Δ orm2Δ cells or Aureobasidin A (AbA) treatment of cells increases the PHS
    levels. B. A comparison of the human and yeast sphingolipid biosynthetic pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LCB1
  - LCB2
  - AUR1
  - SUR1
  - CSH1
  - CSG2
  - IPT1
  - ORM1
  - ORM2
  - SUR2
  - TSC10
  - TSC3
  - GLI3
  - PCBD1
  - DHPS
  - PIEZO1
  - SPTLC1
  - AGXT
  - SPTLC2
  - MED23
  - ABCC9
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
---
